ELI LILLY AND COMPANY Interest Expense
ELI LILLY AND COMPANY (LLY) reported Interest Expense of $179.60 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-04-30
- ELI LILLY AND COMPANY interest expense for the quarter ending 2024-03-31 was $179.60M, a 74.71% increase year-over-year.
- ELI LILLY AND COMPANY interest expense for the quarter ending 2023-12-31 was $138.20M, a 64.52% increase year-over-year.
- ELI LILLY AND COMPANY interest expense for the quarter ending 2023-09-30 was $124.60M, a 52.88% increase year-over-year.
- ELI LILLY AND COMPANY interest expense for the quarter ending 2023-06-30 was $120.30M, a 48.15% increase year-over-year.
- ELI LILLY AND COMPANY interest expense for fiscal 2023 was $485.90M, a 46.53% increase from fiscal 2022.
- ELI LILLY AND COMPANY interest expense for fiscal 2022 was $331.60M, a 2.41% decline from fiscal 2021.
- ELI LILLY AND COMPANY interest expense for fiscal 2021 was $339.80M, a 5.51% decline from fiscal 2020.
- ELI LILLY AND COMPANY interest expense for fiscal 2020 was $359.60M, a 10.23% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | $179.60M 10-Q · filed 2024-04-30 | $317.80M derived: sum of 2 quarters · filed 2024-04-30 | $442.40M derived: sum of 3 quarters · filed 2024-04-30 | $562.70M derived: sum of 4 quarters · filed 2024-04-30 | |||
| 2023-12-31 | $138.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $262.80M derived: sum of 2 quarters · filed 2024-02-21 | $383.10M derived: sum of 3 quarters · filed 2024-02-21 | $485.90M 10-K · filed 2024-02-21 | |||
| 2023-09-30 | $124.60M 10-Q · filed 2023-11-02 | $244.90M derived: sum of 2 quarters · filed 2023-11-02 | $347.70M 10-Q · filed 2023-11-02 | $431.70M derived: sum of 4 quarters · filed 2024-04-30 | |||
| 2023-06-30 | $120.30M 10-Q · filed 2023-08-08 | $223.10M 10-Q · filed 2023-08-08 | $307.10M derived: sum of 3 quarters · filed 2024-04-30 | $388.60M derived: sum of 4 quarters · filed 2024-04-30 | |||
| 2023-03-31 | $102.80M 10-Q · filed 2024-04-30 | $186.80M derived: sum of 2 quarters · filed 2024-04-30 | $268.30M derived: sum of 3 quarters · filed 2024-04-30 | $349.50M derived: sum of 4 quarters · filed 2024-04-30 | |||
| 2022-12-31 | $84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $165.50M derived: sum of 2 quarters · filed 2024-02-21 | $246.70M derived: sum of 3 quarters · filed 2024-02-21 | $331.60M 10-K · filed 2024-02-21 | |||
| 2022-09-30 | $81.50M 10-Q · filed 2023-11-02 | $162.70M derived: sum of 2 quarters · filed 2023-11-02 | $247.60M 10-Q · filed 2023-11-02 | $329.00M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $81.20M 10-Q · filed 2023-08-08 | $166.10M 10-Q · filed 2023-08-08 | $247.50M derived: sum of 3 quarters · filed 2024-02-21 | $331.10M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $84.90M 10-Q · filed 2023-04-27 | $166.30M derived: sum of 2 quarters · filed 2024-02-21 | $249.90M derived: sum of 3 quarters · filed 2024-02-21 | $336.80M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $81.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $165.00M derived: sum of 2 quarters · filed 2024-02-21 | $251.90M derived: sum of 3 quarters · filed 2024-02-21 | $339.80M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $83.60M 10-Q · filed 2022-11-01 | $170.50M derived: sum of 2 quarters · filed 2022-11-01 | $258.40M 10-Q · filed 2022-11-01 | $347.50M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $86.90M 10-Q · filed 2022-08-04 | $174.70M 10-Q · filed 2022-08-04 | $263.90M derived: sum of 3 quarters · filed 2023-02-22 | $353.50M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $87.80M 10-Q · filed 2022-04-29 | $177.00M derived: sum of 2 quarters · filed 2023-02-22 | $266.60M derived: sum of 3 quarters · filed 2023-02-22 | $354.90M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $89.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $178.80M derived: sum of 2 quarters · filed 2023-02-22 | $267.10M derived: sum of 3 quarters · filed 2023-02-22 | $359.60M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $89.60M 10-Q · filed 2021-10-27 | $177.90M derived: sum of 2 quarters · filed 2021-10-27 | $270.40M 10-Q · filed 2021-10-27 | $366.30M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-06-30 | $88.30M 10-Q · filed 2021-08-03 | $180.80M 10-Q · filed 2021-08-03 | $276.70M derived: sum of 3 quarters · filed 2022-02-23 | $384.10M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-03-31 | $92.50M 10-Q · filed 2021-04-30 | $188.40M derived: sum of 2 quarters · filed 2022-02-23 | $295.80M derived: sum of 3 quarters · filed 2022-02-23 | $406.70M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2019-12-31 | $95.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $203.30M derived: sum of 2 quarters · filed 2022-02-23 | $314.20M derived: sum of 3 quarters · filed 2022-02-23 | $400.60M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | $107.40M 10-Q · filed 2020-10-28 | $218.30M derived: sum of 2 quarters · filed 2020-10-28 | $304.70M 10-Q · filed 2020-10-28 | $362.00M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | $110.90M 10-Q · filed 2020-07-31 | $197.40M 10-Q · filed 2020-07-31 | $254.60M derived: sum of 3 quarters · filed 2021-02-17 | $315.40M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-03-31 | $86.50M 10-Q · filed 2020-05-01 | $143.70M derived: sum of 2 quarters · filed 2021-02-17 | $204.50M derived: sum of 3 quarters · filed 2021-02-17 | $267.80M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $57.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $118.00M derived: sum of 2 quarters · filed 2021-02-17 | $181.30M derived: sum of 3 quarters · filed 2021-02-17 | $242.50M 10-K · filed 2021-02-17 | $272.10M 10-K · filed 2019-02-19 | ||
| 2018-09-30 | $60.80M 10-Q · filed 2019-10-25 | $69.40M 10-Q · filed 2018-11-06 | $124.10M derived: sum of 2 quarters · filed 2019-10-25 | $185.30M 10-Q · filed 2019-10-25 | $193.90M 10-Q · filed 2018-11-06 | $248.20M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | $63.30M 10-Q · filed 2019-08-02 | $124.50M 10-Q · filed 2019-08-02 | $187.40M derived: sum of 3 quarters · filed 2020-02-19 | $249.30M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-03-31 | $61.20M 10-Q · filed 2019-05-02 | $124.10M derived: sum of 2 quarters · filed 2020-02-19 | $186.00M derived: sum of 3 quarters · filed 2020-02-19 | $239.60M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $62.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $124.80M derived: sum of 2 quarters · filed 2020-02-19 | $178.40M derived: sum of 3 quarters · filed 2020-02-19 | $225.00M 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $61.90M 10-Q · filed 2018-11-06 | $115.50M derived: sum of 2 quarters · filed 2018-11-06 | $162.10M 10-Q · filed 2018-11-06 | $213.50M derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2017-06-30 | $53.60M 10-Q · filed 2018-07-25 | $100.20M 10-Q · filed 2018-07-25 | $151.60M derived: sum of 3 quarters · filed 2019-10-24 | $198.80M derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2017-03-31 | $46.60M 10-Q · filed 2018-04-27 | $98.00M derived: sum of 2 quarters · filed 2019-10-24 | $145.20M derived: sum of 3 quarters · filed 2019-10-24 | $188.40M derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2016-12-31 | $51.40M derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $98.60M derived: sum of 2 quarters · filed 2019-10-24 | $141.80M derived: sum of 3 quarters · filed 2019-10-24 | $185.20M 8-K · filed 2019-10-24 | |||
| 2016-09-30 | $47.20M 10-Q · filed 2017-10-27 | $90.40M derived: sum of 2 quarters · filed 2017-10-27 | $133.80M 10-Q · filed 2017-10-27 | $178.00M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-06-30 | $43.20M 10-Q · filed 2017-07-28 | $86.60M 10-Q · filed 2017-07-28 | $130.80M derived: sum of 3 quarters · filed 2018-02-20 | $170.10M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-03-31 | $43.40M 10-Q · filed 2017-05-01 | $87.60M derived: sum of 2 quarters · filed 2018-02-20 | $126.90M derived: sum of 3 quarters · filed 2018-02-20 | $163.70M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2015-12-31 | $44.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $83.50M derived: sum of 2 quarters · filed 2018-02-20 | $120.30M derived: sum of 3 quarters · filed 2018-02-20 | $161.20M 10-K · filed 2018-02-20 | |||
| 2015-09-30 | $39.30M 10-Q · filed 2016-10-28 | $76.10M derived: sum of 2 quarters · filed 2016-10-28 | $117.00M 10-Q · filed 2016-10-28 | $154.40M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $36.80M 10-Q · filed 2016-07-28 | $77.70M 10-Q · filed 2016-07-28 | $115.10M derived: sum of 3 quarters · filed 2017-02-21 | $153.20M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $40.90M 10-Q · filed 2016-04-29 | $78.30M derived: sum of 2 quarters · filed 2017-02-21 | $116.40M derived: sum of 3 quarters · filed 2017-02-21 | $151.90M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $37.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $75.50M derived: sum of 2 quarters · filed 2017-02-21 | $111.00M derived: sum of 3 quarters · filed 2017-02-21 | $148.80M 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $38.10M 10-Q · filed 2015-10-30 | $73.60M derived: sum of 2 quarters · filed 2015-10-30 | $111.40M 10-Q · filed 2015-10-30 | $151.10M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | $35.50M 10-Q · filed 2015-07-30 | $73.30M 10-Q · filed 2015-07-30 | $113.00M derived: sum of 3 quarters · filed 2016-02-19 | $152.80M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | $37.80M 10-Q · filed 2015-04-30 | $77.50M derived: sum of 2 quarters · filed 2016-02-19 | $117.30M derived: sum of 3 quarters · filed 2016-02-19 | $157.60M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $39.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $79.50M derived: sum of 2 quarters · filed 2016-02-19 | $119.80M derived: sum of 3 quarters · filed 2016-02-19 | $160.10M 10-K · filed 2016-02-19 | |||
| 2013-09-30 | $39.80M 10-Q · filed 2014-10-29 | $80.10M derived: sum of 2 quarters · filed 2014-10-29 | $120.40M 10-Q · filed 2014-10-29 | $162.90M derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2013-06-30 | $40.30M 10-Q · filed 2014-07-28 | $80.60M 10-Q · filed 2014-07-28 | $123.10M derived: sum of 3 quarters · filed 2015-02-19 | $170.10M derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2013-03-31 | $40.30M 10-Q · filed 2014-04-28 | $82.80M derived: sum of 2 quarters · filed 2015-02-19 | $129.80M derived: sum of 3 quarters · filed 2015-02-19 | $172.80M derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2012-12-31 | $42.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $89.50M derived: sum of 2 quarters · filed 2015-02-19 | $132.50M derived: sum of 3 quarters · filed 2015-02-19 | $177.80M 10-K · filed 2015-02-19 | |||
| 2012-09-30 | $47.00M 10-Q · filed 2013-10-30 | $90.00M derived: sum of 2 quarters · filed 2013-10-30 | $135.30M 10-Q · filed 2013-10-30 | $185.40M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-06-30 | $43.00M 10-Q · filed 2013-07-26 | $88.30M 10-Q · filed 2013-07-26 | $138.40M derived: sum of 3 quarters · filed 2014-02-19 | $183.40M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-03-31 | $45.30M 10-Q · filed 2013-04-26 | $95.40M derived: sum of 2 quarters · filed 2014-02-19 | $140.40M derived: sum of 3 quarters · filed 2014-02-19 | $185.50M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2011-12-31 | $50.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $95.10M derived: sum of 2 quarters · filed 2014-02-19 | $140.20M derived: sum of 3 quarters · filed 2014-02-19 | $186.00M 10-K · filed 2014-02-19 | |||
| 2011-09-30 | $45.00M 10-Q · filed 2012-10-26 | $90.10M derived: sum of 2 quarters · filed 2012-10-26 | $135.90M 10-Q · filed 2012-10-26 | $179.10M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-06-30 | $45.10M 10-Q · filed 2012-07-27 | $90.90M 10-Q · filed 2012-07-27 | $134.10M derived: sum of 3 quarters · filed 2013-02-21 | $181.30M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-03-31 | $45.80M 10-Q · filed 2012-04-30 | $89.00M derived: sum of 2 quarters · filed 2013-02-21 | $136.20M derived: sum of 3 quarters · filed 2013-02-21 | $183.70M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2010-12-31 | $43.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $90.40M derived: sum of 2 quarters · filed 2013-02-21 | $137.90M derived: sum of 3 quarters · filed 2013-02-21 | $185.50M 10-K · filed 2013-02-21 | -$185.50M 10-K · filed 2011-02-22 | ||
| 2010-09-30 | $47.20M 10-Q · filed 2011-10-28 | $94.70M derived: sum of 2 quarters · filed 2011-10-28 | $142.30M 10-Q · filed 2011-10-28 | $192.50M derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2010-06-30 | $47.50M 10-Q · filed 2011-07-29 | $95.10M 10-Q · filed 2011-07-29 | $145.30M derived: sum of 3 quarters · filed 2012-02-24 | $204.50M derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2010-03-31 | $47.60M 10-Q · filed 2011-04-29 | $97.80M derived: sum of 2 quarters · filed 2012-02-24 | $157.00M derived: sum of 3 quarters · filed 2012-02-24 | $221.30M derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2009-12-31 | $50.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $109.40M derived: sum of 2 quarters · filed 2012-02-24 | $173.70M derived: sum of 3 quarters · filed 2012-02-24 | $261.30M 10-K · filed 2012-02-24 | -$261.30M 10-K · filed 2011-02-22 | ||
| 2009-09-30 | $59.20M 10-Q · filed 2010-10-29 | $123.50M derived: sum of 2 quarters · filed 2010-10-29 | $211.10M 10-Q · filed 2010-10-29 | ||||
| 2009-06-30 | $64.30M 10-Q/A · filed 2010-08-02 | $151.90M 10-Q/A · filed 2010-08-02 | |||||
| 2008-12-31 | -$228.30M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |